Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkatraman Radhakrishnan

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 10, 2026
Neoadjuvant Chemotherapy with Trastuzumab with or without Concurrent Radiotherapy in HER2-Positive Locally Advanced Inoperable Breast Cancer- A Phase 2 Randomized Controlled Trial (NEOTRAC STUDY)Priya Iyer, Arvind Krishnamurthy, Sridevi Velusamy, et al.
Leukemia Research|June 20, 2020
Plasmablastic lymphoma - single centre experience with infusional EPOCH chemotherapyPerumal Kalaiyarasi Jayachandran, Arun Kumar Rajan, Parathan Karunakaran, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 17, 2019
Outcomes of Intensive Treatment of Adult Acute Myeloid Leukemia Patients: A Retrospective Study From a Single CentreJayachandran Perumal Kalaiyarasi, Prasanth Ganesan, Krishnarathinam Kannan, et al.
JCO Global Oncology|January 18, 2024
Dexamethasone-Free Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy: A Double-Blind, Phase III Randomized Controlled Trial (CINV POD study)Venkatraman Radhakrishnan, Kritthivasan Venkatakrishnan, Jayachandran Perumal Kalaiyarasi, et al.
Indian Journal of Pediatrics|April 12, 2024
Management of Intraocular Retinoblastoma: ICMR Consensus GuidelinesRachna Meel, Suyash Kulkarni, Lata Singh, et al.
Leukemia Research|July 21, 2019
Gemcitabine, vinorelbine and dexamethasone: A safe and effective regimen for treatment of relapsed/refractory hodgkin's lymphomaPrasanth Ganesan, Nikita Mehra, Anjana Joel, et al.
Indian Journal of Pediatrics|March 16, 2024
Epidemiology, Diagnosis and Genetics of Retinoblastoma: ICMR Consensus GuidelinesLata Singh, Girish Chinnaswamy, Rachna Meel, et al.
Medical Oncology (Northwood, London, England)|December 18, 2017
Effectiveness of olanzapine in patients who fail therapy with aprepitant while receiving highly emetogenic chemotherapyNikita Mehra, Prasanth Ganesan, Trivadi S Ganesan, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|August 22, 2018
DA-EPOCH-R in Aggressive CD 20 Positive B Cell Lymphomas: Real-World ExperiencePrasanth Ganesan, Trivadi S Ganesan, Harshvardhan Atreya, et al.
Cancer Treatment and Research Communications|July 6, 2022
Forecasting factors and outcomes in hawkish inflammatory breast carcinoma - A single center data explorationGangothri Selvarajan, Venkatraman Radhakrishnan, Perumal Kalaiyarasi Jayachandran, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|July 10, 2026
Neoadjuvant Chemotherapy with Trastuzumab with or without Concurrent Radiotherapy in HER2-Positive Locally Advanced Inoperable Breast Cancer- A Phase 2 Randomized Controlled Trial (NEOTRAC STUDY)Priya Iyer, Arvind Krishnamurthy, Sridevi Velusamy, et al.
Leukemia Research|June 20, 2020
Plasmablastic lymphoma - single centre experience with infusional EPOCH chemotherapyPerumal Kalaiyarasi Jayachandran, Arun Kumar Rajan, Parathan Karunakaran, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 17, 2019
Outcomes of Intensive Treatment of Adult Acute Myeloid Leukemia Patients: A Retrospective Study From a Single CentreJayachandran Perumal Kalaiyarasi, Prasanth Ganesan, Krishnarathinam Kannan, et al.
JCO Global Oncology|January 18, 2024
Dexamethasone-Free Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy: A Double-Blind, Phase III Randomized Controlled Trial (CINV POD study)Venkatraman Radhakrishnan, Kritthivasan Venkatakrishnan, Jayachandran Perumal Kalaiyarasi, et al.
Indian Journal of Pediatrics|April 12, 2024
Management of Intraocular Retinoblastoma: ICMR Consensus GuidelinesRachna Meel, Suyash Kulkarni, Lata Singh, et al.
Leukemia Research|July 21, 2019
Gemcitabine, vinorelbine and dexamethasone: A safe and effective regimen for treatment of relapsed/refractory hodgkin's lymphomaPrasanth Ganesan, Nikita Mehra, Anjana Joel, et al.
Indian Journal of Pediatrics|March 16, 2024
Epidemiology, Diagnosis and Genetics of Retinoblastoma: ICMR Consensus GuidelinesLata Singh, Girish Chinnaswamy, Rachna Meel, et al.
Medical Oncology (Northwood, London, England)|December 18, 2017
Effectiveness of olanzapine in patients who fail therapy with aprepitant while receiving highly emetogenic chemotherapyNikita Mehra, Prasanth Ganesan, Trivadi S Ganesan, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|August 22, 2018
DA-EPOCH-R in Aggressive CD 20 Positive B Cell Lymphomas: Real-World ExperiencePrasanth Ganesan, Trivadi S Ganesan, Harshvardhan Atreya, et al.
Cancer Treatment and Research Communications|July 6, 2022
Forecasting factors and outcomes in hawkish inflammatory breast carcinoma - A single center data explorationGangothri Selvarajan, Venkatraman Radhakrishnan, Perumal Kalaiyarasi Jayachandran, et al.
Pageof 15